Vsee Health

Vsee Health PEG

The PEG Ratio (Price/Earnings-to-Growth) of Vsee Health (VSEE) as of Nov 3, 2026 is 0.19. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.35 — a change of -45.60% (lower).

PEG

0.19

YoY

-45.60%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Vsee Health is 2021 0.19 . PEG Ratio (Price/Earnings-to-Growth) of Vsee Health was 2020 0.35 . It decreases by -45.60% lower compared to the previous year.

The Vsee Health PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2020
0.35 USD
Jan 1, 2021
0.19 USD
The Vsee Health PEG history
YEARPEGYoY
0.19-45.60%
0.35—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vsee Health Stock analysis

What does Vsee Health do? Vsee Health Inc generates revenue through its subsidiaries VSee and iDoc. VSee offers a no-code SaaS platform enabling clinicians and enterprises to build telehealth workflows without programming, providing patient engagement, clinician staffing, remote physical exams, and AI solutions for telesitters and telenursing. iDoc operates as an acute care organization delivering 24/7 neurointensive care, cardiac surgery ICU, and stroke ICU services, offering teleneurointensivists for neuro-critical care. The company's products target healthcare providers seeking efficient telehealth integration and specialized critical care services. VSee's clients include hospitals and healthcare enterprises needing rapid telehealth system deployment, while iDoc serves hospitals requiring specialized neuro-critical care teams. The telehealth platform caters to clinics and hospitals aiming to enhance patient engagement and remote monitoring capabilities. iDoc's services are specifically utilized by facilities managing neuro-ICU, CSICU, and stroke ICU cases, providing expert staffing for critical neurological conditions. The company monetizes through subscription-based SaaS models for VSee's telehealth platform and direct service fees for iDoc's acute care services. VSee's no-code solution appeals to healthcare organizations looking to avoid development costs, while iDoc's specialized staffing model addresses gaps in critical care staffing for neurological emergencies. Both segments target healthcare institutions requiring scalable, specialized digital health solutions. Vsee Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vsee Health stock

PEG Ratio (Price/Earnings-to-Growth) of Vsee Health is 0.19 in 2021.

PEG Ratio (Price/Earnings-to-Growth) of Vsee Health changed from 0.35 to 0.19, representing a -45.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Vsee Health since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Vsee Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Vsee Health

All Key Metrics — Vsee Health